REFERENCES
- Abel N, Contino K, Jain N, et al. Eighth Joint National Committee (JNC-8) guidelines and the outpatient management of hypertension in the African-American population. N Am J Med Sci 2015;7:438–45.
- Hall JE, Granger JP, do Carmo JM, et al. Hypertension: physiology and pathophysiology. Compr Physiol 2012;2:2393–442.
- Niu W, Qi Y. An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS One 2011;6:e24266.
- Padmanabhan S, Caulfield M, Dominiczak AF. Genetic and molecular aspects of hypertension. Circ Res 2015;116:937–59.
- Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239–42.
- Ohashi Y, Kawashima S, Hirata K, et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 1998;102:2061–71.
- Gamboa A, Shibao C, Diedrich A, et al. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension 2007;49:170–7.
- Benjafield AV, Morris BJ. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 2000;13:994–8.
- Jáchymová M, Horký K, Bultas J, et al. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 2001;284:426–30.
- Khawaja MR, Taj F, Ahmad U, et al. Association of endothelial nitric oxide synthase gene G894T polymorphism with essential hypertension in an adult Pakistani Pathan population. Int J Cardiol 2007;116:113–5.
- Li J, Cun Y, Tang WR, et al. Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet Mol Res 2011;10:2202–12.
- Kajiyama N, Saito Y, Miyamoto Y, et al. Lack of association between T-786→C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens Res 2000;23:561–5.
- Olcay A, Ekmekci CG, Ozbek U, et al. Negative association of endothelial nitric oxide gene polymorphism with hypertension in Turkish patients: effect of ecNOS polymorphism on left ventricular hypertrophy. Cardiovasc Ultrasound 2006;4:33.
- Sediri Y, Kallel A, Ayadi I, et al. Lack of association between endothelial nitric oxide synthase gene G894T polymorphism hypertension in the Tunisian population. Prev Med 2010;51:88–9.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–5.
- Gamboa A, Shibao C, Diedrich A, et al. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension 2007;49:170–7.
- Kone BC. Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 2000;168:27–31.
- Tesauro M, Thompson WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000;97:2832–5.
- Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190–3.
- Miyamoto Y, Saito Y, Nakayama M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T→C mutation associated with coronary spastic angina. Hum Mol Genet 2000;9:2629–37.
- Nakayama M, Yoshimura M, Sakamoto T, et al. A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine. Pharmacogenet Genomics 2006;16:339–45.